药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Sulfacytine
Isavuconazole
The serum concentration of Canagliflozin can be increased when it is combined with Isavuconazole.
Sulfacytine
Pitolisant
The serum concentration of Canagliflozin can be decreased when it is combined with Pitolisant.
Sulfacytine
Apalutamide
The serum concentration of Canagliflozin can be decreased when it is combined with Apalutamide.
Sulfacytine
Ertugliflozin
The therapeutic efficacy of Canagliflozin can be increased when used in combination with Ertugliflozin.
Sulfacytine
Lacidipine
Canagliflozin may increase the hypotensive activities of Lacidipine.
Sulfacytine
Acemetacin
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Acemetacin.
Sulfacytine
Betrixaban
The serum concentration of Betrixaban can be increased when it is combined with Canagliflozin.
Sulfacytine
Sodium phosphate, monobasic
Canagliflozin may increase the nephrotoxic activities of Sodium phosphate, monobasic.
Sulfacytine
Landiolol
The risk or severity of hyperkalemia can be increased when Canagliflozin is combined with Landiolol.
Sulfacytine
Mannitol busulfan
The risk or severity of hyperkalemia can be increased when Canagliflozin is combined with Mannitol busulfan.
Sulfacytine
Certoparin
The risk or severity of hyperkalemia can be increased when Canagliflozin is combined with Certoparin.
Sulfacytine
Parnaparin
The risk or severity of hyperkalemia can be increased when Canagliflozin is combined with Parnaparin.
Sulfacytine
Reviparin
The risk or severity of hyperkalemia can be increased when Canagliflozin is combined with Reviparin.
Sulfacytine
Bemiparin
The risk or severity of hyperkalemia can be increased when Canagliflozin is combined with Bemiparin.
Sulfacytine
Aliskiren
The risk or severity of hyperkalemia can be increased when Canagliflozin is combined with Aliskiren.
Sulfacytine
Nadroparin
The risk or severity of hyperkalemia can be increased when Nadroparin is combined with Canagliflozin.
Sulfacytine
Tinzaparin
The risk or severity of hyperkalemia can be increased when Tinzaparin is combined with Canagliflozin.
Sulfacytine
Dalteparin
The risk or severity of hyperkalemia can be increased when Dalteparin is combined with Canagliflozin.
Sulfacytine
Danaparoid
The risk or severity of hyperkalemia can be increased when Danaparoid is combined with Canagliflozin.
Sulfacytine
Sulodexide
The risk or severity of hyperkalemia can be increased when Sulodexide is combined with Canagliflozin.